Page last updated: 2024-11-06

c.i. basic blue 41

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

C.I. Basic Blue 41, also known as Basic Blue 41 or Solvent Blue 35, is a triarylmethane dye. It is a blue-colored dye that is soluble in water and organic solvents. It is used in a variety of applications, including textile dyeing, printing, and the coloring of plastics and paper. The dye is synthesized by reacting a mixture of benzaldehyde, dimethylaniline, and hydrochloric acid. The dye is known to have some toxic effects, and its use is regulated in some countries. It is studied for its potential applications in various fields, including bioimaging, photodynamic therapy, and the development of new optical materials.'

Cross-References

ID SourceID
PubMed CID83008
CHEMBL ID259143
SCHEMBL ID94760
SCHEMBL ID3272019
MeSH IDM0508538

Synonyms (36)

Synonym
12270-13-2
basic blue 41, dye content 40 %
basic blue 41
CHEMBL259143
benzothiazolium, 2-(2-(4-(ethyl(2-hydroxyethyl)amino)phenyl)diazenyl)-6-methoxy-3-methyl-, methyl sulfate (1:1)
2-((4-(ethyl(2-hydroxyethyl)amino)phenyl)azo)-6-methoxy-3-methylbenzothiazolium methyl sulphate
c.i. basic blue 41
einecs 235-546-0
unii-1ecx0j387p
1ecx0j387p ,
ci 11154
ci basic blue 41
ethanol, 2-(ethyl(4-((6-methoxy-3-methyl-2-benzothiazolium)azo)phenyl)amino)-, methyl sulfate
benzothiazolium, 2-((4-(ethyl(2-hydroxyethyl)amino)phenyl)azo)-6-methoxy-3-methyl-, methyl sulfate (salt)
bb41 dye
basic blue
AKOS015895000
basacryl blue x 3gl
anilan blue grl
2-((4-(ethyl(2-hydroxyethyl)amino)phenyl)azo)-6-methoxy-3-methylbenzothiazolium methyl sulfate
basic blue 41 [inci]
SCHEMBL94760
SCHEMBL3272019
DTXSID3051624
AKOS024386560
c.i.basic blue 41
W-110302
mfcd00013334
basic blue 41 (c.i. 11105)
basic blue 41. tech.
2-[n-ethyl-4-[(6-methoxy-3-methyl-1,3-benzothiazol-3-ium-2-yl)diazenyl]anilino]ethanol;methyl sulfate
Q27252322
2-((4-(ethyl(2-hydroxyethyl)amino)phenyl)diazenyl)-6-methoxy-3-methylbenzo[d]thiazol-3-ium methyl sulfate
bb41
basicblue
F77639
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID322957Inhibition of synthetic amyloid beta-42 fibrillation by ThT fluorescence analysis relative to control2007The Journal of biological chemistry, Apr-06, Volume: 282, Issue:14
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
AID322958Inhibition of synthetic amyloid beta-42 fibrillation by light scattering analysis relative to control2007The Journal of biological chemistry, Apr-06, Volume: 282, Issue:14
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
AID322955Inhibition of synthetic amyloid beta-42 oligomerization by ELISA2007The Journal of biological chemistry, Apr-06, Volume: 282, Issue:14
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
AID322956Inhibition of synthetic amyloid beta42 oligomer formation by Western blot2007The Journal of biological chemistry, Apr-06, Volume: 282, Issue:14
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's2 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]